With a combined total of more than 35 years in QARA, our expert collaborators can help you achieve your goals in getting your medical devices to market, being audit-ready and long-term strategic planning.
Preparation of regulatory submissions to FDA:
510(k)
Breakthrough Device Designation (BDD)
De Novo devices
Humanitarian Device Exemption (HDE)
Investigational Device Exemption (IDE)
PMA Annual Report or 30-Day Notice
PMA Supplement - 180-Day, Real Time, Panel Track
Premarket Approval (PMA)
Q-Submission
Advertising and promotion review to ensure compliance with FDA and FTC requirements
■ Post-market Surveillance (PMS):
■ FDA Facility/establishment registration
■ Registration and entries into: